Laparoscopic right donor nephrectomy: endo TA stapler is safe and effective.
Although laparoscopic donor nephrectomy is now a well-accepted alternative to traditional open donor nephrectomy at many transplantation centers, there are always concerns regarding quality of graft and vessels after laparoscopic harvest, especially with right donor nephrectomy. Several methods of graft retrieval have been explored to achieve acceptable graft outcome. We share our initial experience at the Institute of Kidney Diseases and Research Center, Amedabad, India of laparoscopic right donor nephrectomy performed by subcostal open, and pure laparoscopic approach with the use of Endo TA stapler. Nine laparoscopic right donor nephrectomies were performed by the trans-peritoneal approach at our centre from January 2006 to March 2007. In the first five cases, the grafts were retrieved through subcostal incision (Group A) and the last four cases were performed purely laparoscopically by using Endo TA stapler device (Group B). None of the patients needed open conversion. The mean operative time and hospital stay were comparable in each group. The warm ischemia time was longer in pure laparoscopic group (415 seconds) than the subcostal open approach group (176 seconds). The serum creatinine of the recipients on day seven was comparable in both the groups. The recipient surgery was effectively performed with graft retrieved using Endo TA stapler device (Group B) without any compromise to the renal vein length. Our study suggests that the Endo TA stapler device is safe and provides all the benefits of minimally invasive surgery to the donor.
Devra
Amit K
AK
Institute of Kidney Diseases and Research Centre, Ahmedabad, India. devra.amit@gmail.com
Patel
Suhag
S
Shah
Shailesh A
SA
D015415:Biomarkers / Q000097:blood; D003404:Creatinine / Q000097:blood; D006801:Humans; D007194:India; D016030:Kidney Transplantation; D010535:Laparoscopy / Q000009:adverse effects; D007902:Length of Stay; D019520:Living Donors; D009392:Nephrectomy / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods*; D018570:Risk Assessment; D013528:Surgical Staplers / Q000009:adverse effects; D017792:Surgical Stapling / Q000009:adverse effects / Q000295:instrumentation*; D013997:Time Factors; D016896:Treatment Outcome; D052096:Warm Ischemia
D015415:Biomarkers; D003404:Creatinine